233 related articles for article (PubMed ID: 16512995)
1. A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.
Shah HR; Ledbetter L; Diasio R; Saif MW
Clin Colorectal Cancer; 2006 Jan; 5(5):354-8. PubMed ID: 16512995
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions.
Shah SR; Martin R; Dowell JE; Ussery SM
Pharmacotherapy; 2010 Dec; 30(12):1259-65. PubMed ID: 21128758
[TBL] [Abstract][Full Text] [Related]
3. An adverse interaction between warfarin and capecitabine: a case report and review of the literature.
Copur MS; Ledakis P; Bolton M; Morse AK; Werner T; Norvell M; Muhvic J; Chu E
Clin Colorectal Cancer; 2001 Nov; 1(3):182-4. PubMed ID: 12450435
[TBL] [Abstract][Full Text] [Related]
4. An observational study examining the impact of capecitabine on warfarin antithrombotic activity and bleeding complications.
Yood MU; Quesenberry CP; Alford SH; Tsai AL; Wells KE; Yood SM; Ackermann Shiff SP
Curr Med Res Opin; 2006 Feb; 22(2):307-14. PubMed ID: 16466602
[TBL] [Abstract][Full Text] [Related]
5. Adverse interaction between capecitabine and warfarin resulting in altered coagulation parameters and bleeding: case report and review of the literature.
Isaacs K; Haim N
J Chemother; 2005 Jun; 17(3):339-42. PubMed ID: 16038530
[TBL] [Abstract][Full Text] [Related]
6. Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.
Camidge R; Reigner B; Cassidy J; Grange S; Abt M; Weidekamm E; Jodrell D
J Clin Oncol; 2005 Jul; 23(21):4719-25. PubMed ID: 16034047
[TBL] [Abstract][Full Text] [Related]
7. Drug interaction between capecitabine and warfarin: a case report and review of the literature.
Yildirim Y; Ozyilkan O; Akcali Z; Basturk B
Int J Clin Pharmacol Ther; 2006 Feb; 44(2):80-2. PubMed ID: 16502767
[TBL] [Abstract][Full Text] [Related]
8. Increased anticoagulant activity of warfarin used in combination with doxifluridine.
Nakajima M; Genda T; Suehira M; Satoh H; Miki A; Hori S; Sawada Y
Cancer Chemother Pharmacol; 2010 Oct; 66(5):969-72. PubMed ID: 20107800
[TBL] [Abstract][Full Text] [Related]
9. [Increased INR from concomitant use of acenocoumarol and capecitabine].
Tomlow B; Voll ML; Smorenburg CH
Ned Tijdschr Geneeskd; 2012; 156(26):A4793. PubMed ID: 22759711
[TBL] [Abstract][Full Text] [Related]
10. An adverse interaction between warfarin and fluoropyrimidines revisited.
Saif MW
Clin Colorectal Cancer; 2005 Sep; 5(3):175-80. PubMed ID: 16197620
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine-warfarin interaction.
Janney LM; Waterbury NV
Ann Pharmacother; 2005 Sep; 39(9):1546-51. PubMed ID: 16014372
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
13. Surgical workload, risk factors and complications in patients on warfarin with gastrointestinal bleeding.
Som R; Gossage JA; Crane A; Rowe PH
Int J Surg; 2010; 8(1):52-5. PubMed ID: 19883802
[TBL] [Abstract][Full Text] [Related]
14. Warfarin-5-FU interaction--a consecutive case series.
Kolesar JM; Johnson CL; Freeberg BL; Berlin JD; Schiller JH
Pharmacotherapy; 1999 Dec; 19(12):1445-9. PubMed ID: 10600095
[TBL] [Abstract][Full Text] [Related]
15. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
Schultz KT; Bungard TJ
Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
[TBL] [Abstract][Full Text] [Related]
17. Preemptive dose reduction of warfarin in patients initiating metronidazole.
Holt RK; Anderson EA; Cantrell MA; Shaw RF; Egge JA
Drug Metabol Drug Interact; 2010; 25(1-4):35-9. PubMed ID: 21417792
[TBL] [Abstract][Full Text] [Related]
18. Xeloda. Warning: drug interaction increase bleeding risks.
Nursing; 2002 Mar; 32(3):26. PubMed ID: 11902039
[No Abstract] [Full Text] [Related]
19. Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer.
Hata T; Kudo T; Sakai D; Takahashi H; Haraguchi N; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M; Satoh T
Cancer Chemother Pharmacol; 2016 Aug; 78(2):389-96. PubMed ID: 27339150
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records.
Menzin J; White LA; Friedman M; Nichols C; Menzin J; Hoesche J; Bergman GE; Jones C
Thromb Haemost; 2012 Apr; 107(4):662-72. PubMed ID: 22318400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
